HER3 expression and MEK activation in non-small-cell lung carcinoma

View/ Open
Date
2021-04-09Author
Manickavasagar, T
Yuan, W
Carreira, S
Gurel, B
Miranda, S
Ferreira, A
Crespo, M
Riisnaes, R
Baker, C
O'Brien, M
Bhosle, J
Popat, S
Banerji, U
Lopez, J
de Bono, J
Minchom, A
Type
Journal Article
Metadata
Show full item recordCollections
Subject
Science & Technology
Life Sciences & Biomedicine
Respiratory System
ERBB3
HER3
MEK
NSCLC
Research team
Clinical Pharmacology – Adaptive Therapy
Thoracic Oncology
Clinical Pharmacology – Adaptive Therapy
Thoracic Oncology
Language
eng
Date accepted
2021-02-22
License start date
2021-04-09
Citation
LUNG CANCER MANAGEMENT, 2021, pp. ? - ? (12)
Publisher
FUTURE MEDICINE LTD